ANF vs TSLA

ANF has a stable Piotroski F-Score of 6/9, indicating moderate financial health, but lacks an Altman Z-Score, limiting definitive conclusions on bankruptcy risk. The stock trades above both the Graham Number ($81.46) and intrinsic value estimate ($71.89), suggesting overvaluation, despite strong profitability metrics like 40.89% ROE and 12.77% ROA. While revenue growth is positive at 6.80%, earnings are contracting YoY (-5.6%) and QoQ (-14.4%), and insider selling signals caution. Analysts recommend a 'buy' with a high target price of $127.56, but recent price performance shows significant short-term weakness (-24% in 1M).

Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.